Adresses des entreprises Marocaines

1  2  3  4  5  7  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Entreprise Biopharma

Adresse : avenue Hassan II km 2, route de Casa. boite postale 4569.

Ville : Rabat

Téléphone : 0537 69 04 54

Fax : 0537 69 36 32

Code postal : 10000

Activité :

Déscription :

La fiche de l'entreprise Biopharma a eu 3117 visites.

Biopharma est une entreprise marocaine domicilié dans la ville de Rabat

Entreprises de la męme ville

Hôtel Balima

283, avenue Mohammed V boite postale 173


3, rue Ahmed Loukili -ex Safi


25 Bloc T6, avenue elkifah CYM rabat

Imprimerie Tour

10, rue de Pékin , Océan

Ehrimat s.a. (Entreprise générale)

avenue Hassan II km 5,900 Rte. Casa


rue Al Iskandariya (Alexandrie) , imm.Sacar, 2°ét.

E.r.a.c. Nord-Ouest

7, avenue Bin Al Ouidane , Agdal boite postale 1066 -

Gamma Design s.a

quartier Takadoum , IotA, n°8, z.i

Biopharma - résultat depuis le web

-787-701-5555. Search form. Search

-Biopharma MEA is a fast growing company, we working to acquire strong and talented calibers.We are paying ultimate attention to our internal business environment, investing in people development.

-Products : Alferon N Injection® is the only highly purified, natural-source, multispecies alpha interferon product currently approved in the U.S. and Argentina.

-Rentschler Biopharma, independent contract manufacturer for the development and production of biopharmaceuticals.

-MGB Biopharma?s focus is to further develop their completely new class of anti-infective medicine, starting with antibiotics based on Minor Groove Binder (MGBs) compounds.

-PARTNERING. S1 Biopharma is evaluating partnerships, collaborations and out-licensing deals that will enable the company to rapidly advance its sexual dysfunction franchise as well as to accelerate the path to commercialization for its drug candidates in the U.S. and internationally.

-Development and production of molecular biology tests for blood group genotyping, diagnosis of genetic complex diseases and monitoring response to biological therapy

-PDL BioPharma seeks to provide a significant return for its shareholders by acquiring commercial stage pharmaceutical assets with multiple year revenue growth potential as well as late clinical stage pharmaceutical products.

-Enabling the Delivery of Life-Changing Medicines. Our differentiated lipid nano-crystal (LNC) drug delivery platform has the potential to address delivery issues associated with a range of molecules.

-Biologics Contract Development and Manufacturing Therapure Biomanufacturing is more than a CMO (contract manufacturing organization)?we?re a CDMO (contract development and manufacturing organization).